- Home
- AUTL vs BLW Comparison
AUTL vs BLW Comparison
Compare AUTL & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- BLW
- Stock Information
- Founded
- AUTL 2014
- BLW 2003
- Country
- AUTL United Kingdom
- BLW United States
- Employees
- AUTL N/A
- BLW N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- BLW Other Consumer Services
- Sector
- AUTL Health Care
- BLW Consumer Discretionary
- Exchange
- AUTL Nasdaq
- BLW Nasdaq
- Market Cap
- AUTL 609.4M
- BLW 513.9M
- IPO Year
- AUTL 2018
- BLW N/A
- Fundamental
- Price
- AUTL $2.29
- BLW $14.03
- Analyst Decision
- AUTL Strong Buy
- BLW
- Analyst Count
- AUTL 3
- BLW 0
- Target Price
- AUTL $10.20
- BLW N/A
- AVG Volume (30 Days)
- AUTL 1.8M
- BLW 85.9K
- Earning Date
- AUTL 11-12-2024
- BLW 01-01-0001
- Dividend Yield
- AUTL N/A
- BLW 8.83%
- EPS Growth
- AUTL N/A
- BLW N/A
- EPS
- AUTL N/A
- BLW 1.81
- Revenue
- AUTL $10,091,000.00
- BLW N/A
- Revenue This Year
- AUTL $940.05
- BLW N/A
- Revenue Next Year
- AUTL $238.49
- BLW N/A
- P/E Ratio
- AUTL N/A
- BLW $7.73
- Revenue Growth
- AUTL 82.71
- BLW N/A
- 52 Week Low
- AUTL $2.20
- BLW $12.35
- 52 Week High
- AUTL $7.45
- BLW $14.26
- Technical
- Relative Strength Index (RSI)
- AUTL 28.90
- BLW 35.20
- Support Level
- AUTL $2.44
- BLW $13.96
- Resistance Level
- AUTL $2.97
- BLW $14.46
- Average True Range (ATR)
- AUTL 0.18
- BLW 0.10
- MACD
- AUTL -0.04
- BLW -0.04
- Stochastic Oscillator
- AUTL 8.82
- BLW 13.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About BLW Blackrock Limited Duration Income Trust
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.